Data / Form D filings / SignPath Pharma, Inc.
SignPath Pharma, Inc.: Form D filings
SignPath Pharma, Inc., a pharmaceuticals company in Sandy, UT, filed 12 Form D notices with the SEC between 2009 and 2021. The latest, on May 12, 2021, reports $1.6 million sold of a $11 million offering to 18 investors.
Find out what SignPath Pharma, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 7984 South 1300 East, Sandy, UT, 84094
- Phone
- (801) 245-0313
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1455694
The full lists. Form D filings in Utah: 660 rows, $33, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 12, 2021 | New notice | $11,000,000 | $1,561,000 | $9,439,000 | 18 | Jun 1, 2020 | sec.gov |
| Aug 28, 2020 | New notice | $10,000,000 | $525,000 | $9,475,000 | 5 | Jun 1, 2020 | sec.gov |
| Dec 18, 2017 | New notice | $5,000,000 | $235,000 | $4,765,000 | 4 | Nov 30, 2017 | sec.gov |
| Jul 15, 2016 | New notice | $5,000,000 | $245,000 | $4,755,000 | 8 | Mar 31, 2016 | sec.gov |
| Jan 27, 2016 | Amendment | $3,000,000 | $2,359,076 | $640,924 | 36 | Oct 31, 2014 | sec.gov |
| Nov 26, 2014 | New notice | $5,000,000 | $320,000 | $4,680,000 | 3 | Oct 31, 2014 | sec.gov |
| Jun 5, 2014 | Amendment | $5,000,000 | $4,355,500 | $644,500 | 14 | Mar 13, 2013 | sec.gov |
| Mar 22, 2013 | New notice | $5,000,000 | $1,000,000 | $4,000,000 | 1 | Mar 13, 2013 | sec.gov |
| May 4, 2012 | Amendment | $3,000,000 | $1,304,000 | $1,696,000 | 26 | Sep 2, 2011 | sec.gov |
| Oct 4, 2011 | New notice | $3,000,000 | $580,000 | $2,420,000 | 9 | Sep 2, 2011 | sec.gov |
| Jun 1, 2010 | New notice | $2,700,000 | $25,000 | $2,675,000 | 1 | May 12, 2010 | sec.gov |
| Mar 5, 2009 | New notice | $1,000,000 | $0 | $1,000,000 | 3 | Feb 19, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Robert Seguso | Executive Officer, Director | |
| Peter Sordillo | Executive Officer | |
| Arthur Ballon, Ph.D | Executive Officer, Director | |
| Kai Larson | Executive Officer, Director | |
| Timothy Touloukian | Executive Officer |
Every Form D from the week of May 10, 2021 · All recent filings in Utah · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what SignPath Pharma, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.